Efficacy and safety of AZD3199 vs formoterol in COPD: a randomized, double-blind study

BACKGROUND: We investigated the efficacy and safety of AZD3199, a novel inhaled ultra-LABA, with the main aim of establishing a dose that would maintain 24-hour bronchodilation in patients with COPD. METHODS: Patients (n = 329) were randomized to AZD3199 (200, 400 or 800 μg o.d.), formoterol (9 μg b...

Descripción completa

Detalles Bibliográficos
Autores principales: Kuna, Piotr, Ivanov, Yavor, Trofimov, Vasily Ivanovich, Saito, Takefumi, Beckman, Ola, Bengtsson, Thomas, Jorup, Carin, Maltais, François
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2013
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3691744/
https://www.ncbi.nlm.nih.gov/pubmed/23731768
http://dx.doi.org/10.1186/1465-9921-14-64

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3691744/
https://www.ncbi.nlm.nih.gov/pubmed/23731768
http://dx.doi.org/10.1186/1465-9921-14-64

Ejemplares similares